020 7189 9999

Monday to Friday 7.45am - 6.00pm
Saturday 9.30am - 1.30pm

Bestinvest
Fund search

AXA FRAMLINGTON BIOTECH - Fund overview

No Bestinvest rating
Find rated specialist funds


Overview of AXA FRAMLINGTON BIOTECH

The fund targets long term capital appreciation by investing principally in the equity securities of companies in the biotechnology, genomic and medical research industries. The fund invests worldwide, but the bulk of the portfolio will consist of US stocks, reflecting the location of much of the biotech industry.

Standard Initial Charge

5.50% 0.00%

Invest via Bestinvest

to save 5.50%

Find out how to invest

Fund summary

Sector  Specialist
Product type  UNIT TRUST
Launched  November, 2001
Size  £70m
Yield 0.0%
Charging basis  Income
Dividends paid  30/4, 31/10.
Bid price(inc) 59.18p
Bid price(acc) 59.21p

Fund Charges

Standard Initial charge 5.50%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.34%
Annual management charge 1.75%
Total expense ratio 1.86%
Reduction in yield (10yr) 1.89%

Bestinvest says


This is one of the few authorised funds investing in this highly specialist sector. Historically most of the investments have been located in the USA and share price performance has been closely linked to new drug approvals. The fund's focus is on profitable, large / midcap biotech companies developing specialist medicines.

Portfolio

axa framlington biotech asset allocation illustration
Allocation Proportion
Equity 98%
High yield bonds 0%
Quality bonds 0%
Property 0%
Commodities 0%
Hedge 0%
Fund cash 2%
axa framlington biotech equity geographic illustration
Allocation Proportion
UK 3%
Europe 3%
Nth America 94%
Japan 0%
Pacific 0%
Other Equity 0%
axa framlington biotech equity capitalisation illustration
Allocation Proportion
Large Caps 36%
Mid Caps 30%
Small Caps 34%

View all performance data for AXA FRAMLINGTON BIOTECH

Investment process


No information available.

The value of your investments and the income from them can go down as well as up, and you can get back less than you originally invested. Past performance or any yields quoted should not be considered reliable indicators of future returns. Before investing in funds please check the specific risk factors on the key features document or refer to our risk warning notice as some funds can be high risk or complex; they may also have risks relating to the geographical area, industry sector and/or underlying assets in which they invest. Prevailing tax rates and relief are dependent on your individual circumstances and are subject to change.

Bestinvest (Brokers) Ltd & Bestinvest (Consultants) Ltd are authorised and regulated by the Financial Services Authority. This site is for UK Investors only

Version: 4.1.2